Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

LWAY US Equity

Lifeway Foods, Inc.Consumer Staples · Dairy Products · CIK 814586 · FY ends Dec 31
$25.93
+0.02 (+0.08%)
USD · as of 2026-08-21 · marketstack

LWAY · 10-K · period ended 2021-12-31

← all LWAY documents
filed 2022-07-21 · EDGAR original ↗

Our rendering of the filing — original pagination and typography are not reproduced, and tables are reduced to their short label cells (the figures live on FA). Nothing is summarized: every line below is the filing's own text.

blocks 7891,388 of 2,801239k characters rendered

ITEM 7

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of the financial condition

and results of operations as of and for the years ended December 31, 2021 and 2020 should be read in conjunction with the audited consolidated

financial statements and the notes to those statements that are included elsewhere in this Annual Report on Form 10-K. In addition to

historical information, the following discussion contains certain forward-looking statements within the “safe harbor” provisions

of the Private Securities Litigation Reform Act of 1995. These statements relate to our future plans, objectives, expectations and intentions.

These statements may be identified by the use of words such as "may," "could," "believe," "future,"

"depend," "expect," "will," "result," "can," "remain," "assurance,"

"subject to," "require," "limit," "impose," "guarantee," "restrict," "continue,"

"become," "predict," "likely," "opportunities," "effect," "change," "future,"

"predict," and "estimate," and similar terms or terminology, or the negative of such terms or other comparable terminology.

Although we believe the expectations expressed in these forward-looking statements are based on reasonable assumptions within the bounds

of our knowledge of our business, our actual results could differ materially from those discussed in these statements. Factors that could

contribute to such differences include, but are not limited to, those discussed in the “Risk Factors” section in Part I, Item

1A. We undertake no obligation to update publicly any forward-looking statements for any reason even if new information becomes available

or other events occur in the future.

Restatement of Previously Issued Consolidated

Financial Statements

During the preparation of our fiscal 2021 consolidated

financial statements, we identified a material error in the accounting for our deferred income tax liabilities and goodwill. Specifically,

in connection with our 2009 acquisition of Fresh Made, Inc., we did not record a deferred income tax liability and corresponding increase

to goodwill related to the difference in the book and income tax bases for the $3.7 million Fresh Made indefinite-lived brand name intangible

asset acquired. The error resulted in a $1.18 million understatement of both deferred income tax liabilities and goodwill of as of January

1, 2020. The Restatement had no impact on our Consolidated Statements of Operations, Consolidated Statements of Cash Flows, or Consolidated

Statements of Stockholders’ Equity during 2021 and 2020. The impact of the Restatement on periods prior to 2020 had no effect on

opening retained earnings as of January 1, 2020.

The accounting adjustments required to correct

the error in the consolidated financial statements for the year ended December 31, 2020 as a result of completing the restatement

process are described in Note 1 – Basis of presentation - Restatement of Previously Issued Consolidated Financial Statements included

in “Part II – Item 8 – Financial Statements and Supplementary Data.” Note 17 – Restatement of previously

issued unaudited consolidated financial statements presents the accounting adjustments to correct the error in the quarterly consolidated

financial statements for the fiscal quarters in 2020 and 2021.

The accompanying Management’s Discussion

and Analysis of Financial Condition and Results for Operation gives effect to the Restatement adjustments made to the previously reported

Consolidated Financial Statements for the year ended December 31, 2020.

Recent Developments

COVID-19 Pandemic Impact

In December 2019, COVID-19 was first reported

and subsequently characterized by the World Health Organization ("WHO") as a pandemic in March 2020. In an effort to reduce

the global transmission of COVID-19, various policies and initiatives have been implemented by governments around the world, including

orders to close businesses not deemed "essential", shelter-in-place orders enacted by state and local governments, and the practice

of social distancing measures when engaging in essential activities.

During the first quarter of 2020, Management,

anticipating the spread of COVID-19 and its effects, implemented a plan to mitigate effects of COVID-19 on supply and transportation of

materials used to make and package our products, staffing, and transportation of our products to customers. Management’s proactive

planning allowed the Company to avoid disruption to its manufacturing facilities and production, transportation, and sales and to meet

the increased demand without delay. The Company has maintained full production capacity available at all locations and does not anticipate

manufacturing or staffing disruptions in the near term.

To date, we

have seen increased customer and consumer demand for our products. We have not experienced significant supply chain disruptions or labor

supply shortages and we have continued to be able to satisfy customer and consumer demand for our products. However, the COVID-19 pandemic,

or any future pandemic, may limit the availability of, or increase the cost of, employees, ingredients, packaging and other inputs necessary

to produce our products, and our operations may be negatively impacted. In 2021, our costs increased primarily due to inflationary price

increases of milk, other ingredients, packaging materials, and freight. However, because of market conditions or for competitive reasons,

our pricing actions may sometimes lag input cost changes, or we may not be able to pass along the full effect of increases in raw materials

and other input costs as we incur them.

Recently, in 2022, social distancing,

shelter-in-place and work-from-home mandates and recommendations have begun to be reduced or eliminated. The increased customer demand

for our products as consumers increased their at-home consumption and e-commerce purchasing during the COVID-19 pandemic may change or

decrease due to the decrease in social distancing and stay-at-home and work-from-home mandates and recommendations. We are unable to predict

the nature and timing of when such change may occur, if at all.

Results of Operations

Comparison of Year Ended December 31, 2021

to Year Ended December 31, 2020 (in 000’s)

December 31,

$ % $ %

Other income (expense):

Gain on investments 2 0.0 % 4 0.0 %

Loss on sales or property and equipment (88 ) (0.1 %) (28 ) (0.0 %)

Total other income (expense) (264 ) (0.2 %) (95 ) (0.1 %)

Income before provision for income taxes 5,616 4.7 % 4,828 4.7 %

Net Sales

Net sales were $119,065 for the year ended December

31, 2021, an increase of $17,039 or 16.7% versus prior year. The net sales increase was primarily driven by higher volumes of our branded

drinkable kefir and, to a lesser extent, the favorable impact of our acquisition of Glen Oaks Farms during the third quarter of 2021.

Approximately 11% of the net sales increase results from our acquisition of Glen Oaks Farms during the third quarter of 2021. Approximately

20% of the net sales increase results from the Farmers to Families Food Box program with the USDA, which began during the middle of the

first quarter of 2021 and ended during May 2021.

Gross Profit

Gross profit as a percentage of net sales decreased

to 24.1% during the year ended December 31, 2021 from 26.4% during the same period in 2020. The decrease versus the prior year was primarily

due to the unfavorable impact of milk pricing, and the inflationary price increases of other ingredients, packaging materials, and freight,

partially offset by the decrease in depreciation expense and favorable labor efficiency due to increased volumes. We took favorable pricing

actions beginning in December 2021 to recover input and freight cost inflation. However, for market conditions or competitive reasons,

our pricing actions may also lag input cost changes, or we may not be able to pass along the full effect of increases in raw materials

and other input costs as we incur them.

Selling Expenses

Selling expenses increased by $900 to $11,097

during the year ended December 31, 2021 from $10,197 during the same period in 2020. The increase versus prior year is primarily due to

increased investment in advertising and marketing programs, partially offset by lower compensation and broker expense.

General and Administrative Expenses

General and administrative expenses decreased

$50 to $11,611 during the year ended December 31, 2021 from $11,661 during the same period in 2020. The decrease is primarily a result

of lower compensation, related party consulting, and office rent expense, partially offset by higher employee incentive compensation expense.

Provision for Income Taxes

The provision for income taxes includes federal,

state and local income taxes. The provision for income taxes was $2,305 and $1,596 during the year ended December 31, 2021 and 2020, respectively.

Our effective income tax rate was 41.0% in 2021

compared to 33.1% in 2020. The statutory Federal and state tax rates remained consistent from 2020 to 2021. The Company has a number of

items that are nondeductible or are discrete adjustments to tax expense. The Company consistently reflects non-deductible officer compensation

expense, non-deductible compensation expense related to equity incentive awards and separate state tax rates from year to year. Although

similar items were reflected in 2021, the percentage effect is different due to the difference in pre-tax income in 2021 compared to 2020.

Our effective tax rate may change from period

to period based on recurring and non-recurring factors including the relative mix of pre-tax earnings (or losses), the underlying income

tax rates applicable to various state and local taxing jurisdictions, enacted tax legislation, the impact of non-deductible items, changes

in valuation allowances, and the expiration of the statute of limitations in relation to unrecognized tax benefits. We record discrete

income tax items such as enacted tax rate changes in the period in which they occur.

Section 162(m) of the Internal Revenue Code (the

“Code”) limits the deductibility of compensation paid to certain of our executives. Under Section 162(m), no tax deduction

in taxable years beginning after December 31, 2017 is allowed for compensation paid to any covered employee to the extent that the total

compensation for that covered employee exceeds $1,000,000 in any taxable year.

Income taxes are discussed

in Note 10 in the Notes to the Consolidated Financial Statements.

Net Income (Loss)

We reported net income of $3,311 or $0.21 per

basic and diluted common share for the year ended December 31, 2021 compared to net income of $3,232 or $0.21 per basic and diluted common

share in the same period in 2020.

Liquidity and Capital Resources

Cash Flow

At this time, the COVID-19 pandemic has not materially

impacted our operations. We expect to meet our foreseeable liquidity and capital resource requirements, and to ensure the continuation

of the Company as a going concern, through anticipated cash flows from operations, our revolving credit facility and cash and cash equivalents.

If additional borrowings are needed, approximately $2,223 was available under the Revolving Credit Facility as of December 31, 2021. See

Note 7 to our Consolidated Financial Statements for additional information regarding our Revolving Credit Facility. We are in compliance

with the terms of the Credit Agreement and expect to meet foreseeable financial requirements. The success of our business and financing

strategies will continue to provide us with the financial flexibility to take advantage of various opportunities as they arise. Given

the dynamic nature of COVID-19, we will continue to assess our liquidity needs while continuing to manage our discretionary spending and

investment strategies.

The ultimate

impact that the COVID-19 pandemic or any future pandemic or disease outbreak will have on our business and our consolidated results of

operations is uncertain.

Sources and Uses of Cash

Lifeway had a net increase in cash and cash equivalents

of $1,307 and $4,090 during the years ended December 31, 2021 and 2020, respectively. The drivers of the year over year change are as

follows:

Net cash provided by operating activities was

$6,144 in 2021 compared to $6,385 in 2020, a decrease in cash provided of $241. The decrease is primarily due to the change in working

capital.

Net cash used in investing activities was $7,722

in 2021 compared to $1,890 in 2020, an increase in cash used of $5,832. The increase reflects the August 2021 acquisition of Glen Oak

Farms, Inc. The $5,800 acquisition purchase price was funded through proceeds from our new $5,000 term loan and existing cash. Capital

spending was $1,922 in 2021 compared to $1,895 in 2020. Our capital spending is focused in three core areas: growth, cost reduction, and

facility improvements. Growth capital spending supports new product innovation and enhancements. Cost reduction and facility improvements

support manufacturing efficiency, safety and productivity.

Net cash provided by financing activities was

$2,885 during the year ended December 31, 2021 compared to net cash used in financing activities of $405 in the same period in 2020.

The increase in net cash provided by financing activities relates to the term loan entered into during August 2021 in connection with

the acquisition of Glen Oaks Farms, Inc. See the Debt Obligations section below for further detail.

On June 24, 2021, Lifeway’s Board authorized

a plan to repurchase up to 250 shares of Common Stock in the open market within 24 months at no more than $10 per share. We repurchased

all 250 shares of common stock at a cost of $1,583 during the three-month period ended September 30, 2021. We intend to hold repurchased

shares in treasury for general corporate purposes, including issuances under our 2015 Omnibus Incentive Plan. Treasury shares are accounted

for using the cost method.

Debt Obligations

On August 18, 2021, Lifeway entered into the

Fourth Modification (the “Fourth Modification”) to the Amended and Restated Loan and Security Agreement (as amended and modified

from time to time, the “Credit Agreement”) with its existing lender and certain of its subsidiaries. The Fourth Modification

amends the Credit Agreement to provide for, among other things, a $5 million term loan by the existing lender to the borrowers to be

repaid in quarterly installments of principal and interest over a term of five years (the “Term Loan”). The termination

date of the Term Loan is August 18, 2026, unless earlier terminated. Except for the addition of the Term Loan, the Credit Agreement remains

substantively unchanged and in full force and effect.

As of December 31, 2021, we had $2,777 outstanding

under the Revolving Credit Facility and $4,470 outstanding under the note payable, net of $30 of unamortized deferred financing fees.

We had $2,223 available for future borrowings under the Revolving Credit Facility as of December 31, 2021. As amended, all outstanding

amounts under the Loans bear interest, at Lifeway’s election, at either the lender Base Rate (the Prime Rate minus 1.00%) or the

LIBOR plus 1.95%, payable monthly in arrears. Lifeway is also required to pay a quarterly unused line fee of 0.20% on the Revolving Credit

Facility and, in conjunction with the issuance of any letters of credit, a letter of credit fee of 0.20%. The interest rate on debt outstanding

under the Loans as of December 31, 2021 was 2.15%.

We are in compliance with all applicable financial

debt covenants as of December 31, 2021. See Note 7 to our Consolidated Financial Statements for additional information regarding our

indebtedness and related agreements.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet financing

arrangements as defined in Item 303(a)(4) of Regulation S-K.

Contractual Obligations

Not applicable.

Critical Accounting Estimates

Critical accounting estimates are those estimates

made in accordance with U.S. GAAP that involve a significant level of estimation uncertainty and have had or are reasonably likely to

have a material impact on the financial condition or results of operations of the registrant. In many cases, the accounting treatment

of a particular transaction is specifically dictated by U.S. GAAP with no need for the application of our judgement. In certain circumstances,

the preparation of our Consolidated Financial Statements in conformity with U.S. GAAP requires us to use our judgment to make certain

estimates and assumptions. These estimates affect the reported amounts of assets and liabilities and disclosures of contingent assets

and liabilities at the date of the Consolidated Financial Statements and the reported amounts of net sales and expenses during the reporting

period. We believe in the quality and reasonableness of our critical accounting estimates; however, materially different amounts might

be reported under different conditions or using assumptions, estimates or making judgments different from those that we have applied.

Management has discussed the development and selection of these critical accounting policies, as well as our significant accounting policies

(see Note 2 to the Consolidated Financial Statements), with the Audit Committee of our Board of Directors. We have identified the policies

described below as our critical accounting policies.

Goodwill and intangible asset valuation

Goodwill totaled $11,704 as of December 31, 2021.

The Company completed its annual goodwill impairment analysis as of December 31, 2021. Our assessment did not result in an impairment.

Goodwill represents the excess purchase price over the fair value of the net tangible and other identifiable intangible assets acquired.

We estimate the fair value of our one reporting unit annually (as of December 31), or more frequently if certain conditions exist, using

a combination of the fair values derived from both the income approach and the market approach. Under the income approach, we calculate

the fair value of a reporting unit based on the present value of estimated future cash flows. Cash flow projections are based on our estimates

of revenue growth rates and operating margins, taking into consideration industry and market conditions. The discount rate used to determine

the present value of future cash flows is based on the weighted-average cost of capital adjusted for the relevant risk associated with

business-specific characteristics and the uncertainty related to the business's ability to execute on the projected cash flows. The market

approach estimates fair value based on market multiples of revenue and earnings derived from comparable publicly-traded companies with

similar operating and investment characteristics. The resulting fair value, based on the income and market approaches, is then compared

to the carrying value to determine if impairment is necessary.

We reviewed our indefinite lived intangible assets,

which consist of brand names totaling $3,700 as of December 31, 2021, using the relief from royalty method. Significant assumptions include

the royalty rate, revenue growth rates, and discount rates. Our assumptions were based on historical performance and management estimates

of future performance. Our assessment did not result in an impairment in 2021.

Sales discounts & allowance.

We offer various trade promotions and sales incentive

programs to customers and consumers. From time to time, we grant certain sales discounts to customers which are classified as a reduction

in sales. The measurement and recognition of discounts and allowances involve the use of judgment and our estimates are made based on

historical experience and specific customer program accruals. Differences between estimated and actual discount and allowance costs are

normally not material and are recognized in earnings in the period such differences are determined. The process for analyzing trade promotion

programs could impact our results of operations and trade spending accruals depending on how actual results of the programs compare to

original estimates. As of December 31, 2021, we had $1,170 of accrued discounts and allowances.

Share-based compensation.

Certain employees and non-employee directors

receive various forms of share-based payment awards and we recognize compensation expense for these awards based on their grant date

fair values. The fair values of stock option awards are estimated on the grant date using the Black-Scholes option pricing model, which

incorporates certain assumptions regarding the expected term of an award and expected stock price volatility. The expected term is determined

under the simplified method, using an average of the contractual term and vesting period of the stock options. The expected volatility

is based on the historic volatility of our common stock. We do not estimate forfeitures in measuring the grant date fair value, but rather

account for forfeitures as they occur. Key assumptions are described in further detail in Note 11 to our consolidated financial statements.

No stock options were issued during 2021 or 2020.

Income taxes.

We pay income taxes based on tax statutes, regulations,

and case law of the various jurisdictions in which we operate. At any given time, multiple tax years are subject to audit by the various

taxing authorities. Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are

recognized for the future tax effects of temporary differences between financial and income tax reporting using tax rates in effect for

the years in which the differences are expected to reverse.

We recognize an income tax benefit from an uncertain

tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based

on the technical merits of the position. The income tax benefit recognized in our financial statements from such a position is measured

based on the largest estimated benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. These judgments

and estimates made at a point in time may change based on the outcome of tax audits and changes to, or further interpretations of, regulations.

If such changes take place, there is a risk that our tax rate may increase or decrease in any period, which would impact our earnings.

Future business results may affect deferred tax liabilities or the valuation of deferred tax assets over time.

Recent Accounting Pronouncements.

See Note 2, Summary of Significant Accounting

Policies, in the Notes to the Consolidated Financial Statements included in Item 8 of this Annual Report on Form 10-K for information

regarding recent accounting pronouncements.

ITEM 7A

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable

ITEM 8

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Report of Independent Registered Accounting Firm (PCAOB ID 199) F-1

Consolidated Balance Sheets as of December 31, 2021 and 2020 F-2

Notes to Consolidated Financial Statements (as restated) F-6

Report of Independent Registered Public

Accounting Firm

To the Board of Directors and

Stockholders of Lifeway Foods, Inc. and Subsidiaries:

Opinion on the Financial Statements

We have audited the accompanying consolidated

balance sheets of Lifeway Foods, Inc. and Subsidiaries (the “Company”) as of December 31, 2021 and 2020, the related consolidated

statements of operations, stockholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2021,

and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present

fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations

and its cash flows for each of the years in the two-year period ended December 31, 2021, in conformity with accounting principles generally

accepted in the United States of America.

Restatement of the 2020 Financial Statements

As discussed in Note 1, the 2020 financial statements

have been restated to correct a misstatement.

Basis for Opinion

These financial statements are the responsibility

of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our

audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB")

and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable

rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the

standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial

statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged

to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding

of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s

internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess

the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond

to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating

the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

Critical audit matters are matters arising from the current period

audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to

accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex

judgments. We determined that there are no critical audit matters.

/s/ Mayer Hoffman McCann P.C.

We have served as the Company's auditor since

2015

Chicago, Illinois

July 21, 2022

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

December 31, 2021 and 2020

(In thousands)

December 31,

Current assets

Cash and cash equivalents $ 9,233 $ 7,926

Prepaid expenses and other current assets 1,254 1,163

Refundable income taxes 344 31

Operating lease right-of use asset 216 345

Intangible assets

Goodwill and indefinite-lived intangibles 15,404 14,004

Other intangible assets, net 4,278 –

Current liabilities

Current portion of note payable $ 1,000 $ –

Operating lease liabilities 85 165

Other long-term liabilities 147 77

Commitments and contingencies – –

Stockholders’ equity

Preferred stock, no par value; 2,500 shares authorized; none issued – –

Total liabilities and stockholders’ equity $ 70,874 $ 61,249

See accompanying notes to consolidated financial

statements

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

For the Years Ended December 31, 2021 and 2020

(In thousands, except per share data)

Other income (expense):

Realized gain on investments, net 2 4

Loss on sale of property and equipment (88 ) (28 )

Other (expense) income (62 ) 47

Total other income (expense) (264 ) (95 )

Income before provision for income taxes 5,616 4,828

Basic earnings per common share $ 0.21 $ 0.21

Diluted earnings per common share $ 0.21 $ 0.21

Weighted average number of shares outstanding - Basic 15,537 15,597

Weighted average number of shares outstanding - Diluted 15,773 15,766

See accompanying notes to consolidated financial

statements

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Stockholders’

Equity

For the Years Ended December 31, 2021 and 2020

(In thousands)

Common Stock

Issued In treasury Paid-In Retained Total

Shares $ Shares $ Capital Earnings Equity

Cumulative impact of change in accounting principles, net of tax – – – – – – –

Treasury stock purchased – – (179 ) (405 ) – – (405 )

Stock-based compensation – – – – 282 – 282

Treasury stock purchased – – (250 ) (1,583 ) – – (1,583 )

Stock-based compensation – – – – 673 – 673

See accompanying notes to consolidated financial

statements

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

For the Years Ended December 31, 2021 and 2020

(In thousands)

Cash flows from operating activities:

Adjustments to reconcile net income to operating cash flow:

Depreciation and amortization 2,873 3,239

Non-cash interest expense 11 23

Non-cash rent expense 1 (37 )

Bad debt expense 2 (6 )

Deferred Revenue (30 ) (91 )

Loss on sale of property and equipment 88 28

(Increase) decrease in operating assets:

Refundable income taxes (313 ) 649

Prepaid expenses and other current assets (91 ) 423

Increase (decrease) in operating liabilities:

Operating lease asset amortization/liability – –

Accrued income taxes 72 500

Net cash provided by operating activities 5,564 6,385

Cash flows from investing activities:

Purchases of property and equipment (1,922 ) (1,895 )

Proceeds from sale of property and equipment – 5

Acquisition, net of cash acquired (5,220 ) –

Net cash used in investing activities (7,142 ) (1,890 )

Cash flows from financing activities:

Purchase of treasury stock (1,583 ) (405 )

Payment of deferred financing cost (32 ) –

Proceeds from note payable 5,000 –

Repayment of note payable (500 ) –

Net cash provided by (used in) financing activities 2,885 (405 )

Net increase in cash and cash equivalents 1,307 4,090

Cash and cash equivalents at the beginning of the period 7,926 3,836

Cash and cash equivalents at the end of the period $ 9,233 $ 7,926

Supplemental cash flow information:

Cash paid for income taxes, net of (refunds) $ 2,288 $ (426 )

Cash paid for interest $ 102 $ 99

Non-cash investing activities

Business acquisition escrow payable $ 580 $ –

Non-cash financing activities

Issuance of common stock under equity incentive plans $ – $ 522

See accompanying notes to consolidated financial

statements

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

(In thousands)

Note 1 – Basis of presentation

The consolidated financial statements and accompanying

notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

The consolidated financial statements include all of the assets, liabilities and results of operations of Lifeway’s wholly owned

subsidiaries (collectively “Lifeway” or the “Company”). All inter-company balances and transactions have been

eliminated in the consolidated financial statements.

Restatement of Previously Issued Consolidated

Financial Statements

Lifeway has restated herein its consolidated financial

statements as of and for the year ended December 31, 2020. In addition, the Company has restated its unaudited quarterly consolidated

financial statements for the first three quarters of the years ended December 31, 2020 and 2021, as presented in Note 17 – Correction

of previously issued unaudited consolidated financial statements. Lifeway has also restated impacted amounts within the notes to the consolidated

financial statements, as applicable.

Restatement Background

During the preparation of the fiscal 2021 consolidated

financial statements, the Company identified an error in the accounting for its deferred income tax liabilities and goodwill. Specifically,

in connection with its 2009 acquisition of Fresh Made, Inc., the Company did not record a deferred income tax liability and corresponding

increase to goodwill related to the difference in the book and income tax bases for the $3,700 Fresh Made indefinite-lived brand name

intangible asset acquired. The error resulted in a $1,180 understatement- of both deferred income tax liabilities and goodwill of as of

January 1, 2020. The Restatement had no impact on the Company’s Consolidated Statements of Operations, Consolidated Statements of

Cash Flows, or Consolidated Statements of Stockholders’ Equity during 2021 and 2020. The impact of the Restatement on periods prior

to 2020 had no effect on opening retained earnings as of January 1, 2020.

The following table summarizes the impact of the

restatement adjustments on the Consolidated Balance Sheet for the year ended December 31, 2020.

Schedule of restatement adjustments

As Previously Reported Restatement Adjustment As Restated

Current assets

Cash and cash equivalents $ 7,926 $ – $ 7,926

Prepaid expenses and other current assets 1,163 – 1,163

Refundable income taxes 31 – 31

Operating lease right-of use asset 345 – 345

Intangible assets

Other intangible assets, net – – –

Current liabilities

Operating lease liabilities 165 – 165

Other long-term liabilities 77 – 77

Commitments and contingencies – – –

Stockholders’ equity

Preferred stock, no par value; 2,500 shares authorized; none issued – – –

Note 2 – Summary of significant accounting

policies

Use of estimates

The preparation of consolidated financial statements

in conformity with U.S. GAAP requires management to use judgement to make estimates and assumptions that affect the reported amounts of

assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the

reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates. Significant

estimates made in preparing the consolidated financial statements include the reserve for promotional allowances, the valuation of goodwill

and intangible assets, stock-based and incentive compensation, and deferred income taxes.

During the fourth quarter of 2021, the Company

completed an assessment of the useful life of its indefinite-lived brand name intangible asset and determined that it should adjust the

estimated useful life from an indefinite length to 15 years. The change in accounting estimate will be effective January 1, 2022, at which

time the Company will begin amortizing the asset over 15 years. The future amortization expense is included in the five-year intangible

asset amortization table in Note 5 – Goodwill and Intangible Assets.

Going Concern

The Company follows the guidance in Accounting

Standards Codification (“ASC”) 205-40, Presentation of Financial Statements - Going Concern which requires management to assess

an entity’s ability to continue as a going concern and to provide related disclosure in certain circumstances. There were no conditions

or events, when considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern

within one year after the date the financial statements are issued.

Cash and cash equivalents

Lifeway considers cash and all highly liquid investments

purchased with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which

approximates or equals fair value due to their short-term nature.

Lifeway from time to time may have bank deposits

in excess of insurance limits of the Federal Deposit Insurance Corporation. The Company places its cash and cash equivalents with high

credit quality financial institutions. Lifeway has not experienced any losses in such accounts and believes the financial risks associated

with these financial instruments are minimal.

The Company has $580 of restricted cash which

is included in cash and cash equivalents as of December 31, 2021. The restricted cash balance represents escrow funds deposited by Lifeway

in connection with the September 18, 2021 acquisition of certain assets of Glen Oaks Farms, Inc. The funds are security for the liability

and indemnity obligations of seller as defined under the asset purchase agreement. The funds will remain in escrow for twelve months from

the acquisition closing date, at which time the funds, less any amounts for outstanding seller obligations, will be remitted to the sellers.

Revenue Recognition

Lifeway sells food and beverage products across

select product categories to customers predominantly within the United States (see Note 12 - Segments, Products and Customers). The Company

also sells bulk cream, a byproduct of its fluid milk manufacturing process. In accordance with ASC 606, Revenue from Contracts with Customers,

Lifeway recognizes revenue when control over the products transfers to its customers, which generally occurs upon delivery to its customers

or their common carriers. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive

in exchange for these goods or services, using the five-step method required by ASC 606.

For the Company, the contract is the approved

sales order, which may also be supplemented by other agreements that formalize various terms and conditions with customers. The Company

applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the

customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining

to the customer.

Performance obligations promised in a contract

are identified based on the goods or services that will be transferred to the customer, which is the delivery of food products which provide

immediate benefit to the customer.

Lifeway accounts for product shipping and handling

as fulfillment activities with revenues for these activities recorded within net revenue and costs recorded within cost of goods sold.

Any taxes collected on behalf of government authorities are excluded from net revenues.

Variable consideration, which typically includes

volume-based rebates, known or expected pricing or revenue adjustments, such as trade discounts, allowances for non-saleable products,

product returns, trade incentives and coupon redemption, is estimated utilizing the most likely amount method.

Key sales terms, such as pricing and quantities

ordered, are established on a frequent basis such that most customer arrangements and related incentives have a one year or shorter duration.

As such, the Company does not capitalize contract inception costs and it capitalizes product fulfillment costs in accordance with U.S.

GAAP and its inventory policies. Lifeway does not have any significant deferred revenue or unbilled receivables at the end of a period.

It generally does not receive noncash consideration for the sale of goods, nor does it grant payment financing terms greater than one

year.

Accounts Receivable

Lifeway provides credit terms to customers in-line

with industry standards and maintain allowances for potential credit losses based on historical experience. Customer balances are written

off after all collection efforts are exhausted. Estimated product returns, which have not been material, are deducted from sales at the

time of revenue recognition. The Company does not charge interest on past due accounts receivable.

Inventories

Inventories are stated at the lower of cost or

net realizable value, valued on a first in, first out basis (“FIFO”). The costs of finished goods inventories include raw

materials, direct labor, and overhead costs. Inventories are stated net of reserves for excess or obsolete inventory.

Property, plant and equipment

Property, plant and equipment are recorded at

cost. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets as follows:

Schedule Of Property And Equipment, Estimated Useful Lives

Asset Useful Life

Buildings and improvements 10 – 39 years

Machinery and equipment 5 – 12 years

Office equipment 3 – 7 years

Vehicles 5 years

Leasehold improvements Shorter of expected useful life or lease term

The Company performs impairment tests when circumstances

indicate that the carrying value of an asset may not be recoverable. Expenditures for repairs and maintenance, which do not improve or

extend the life of the assets, are expensed as incurred.

Intangible Assets

Goodwill and indefinite-lived intangible assets

Goodwill represents the excess purchase price

over the fair value of the net tangible and other identifiable intangible assets acquired. Lifeway estimates the fair value of its one

reporting unit annually (as of December 31), or more frequently if certain conditions exist, using a combination of the fair values derived

from both the income approach and the market approach. Under the income approach, it calculates the fair value of a reporting unit based

on the present value of estimated future cash flows. Cash flow projections are based on the Company’s estimates of revenue growth

rates and operating margins, taking into consideration industry and market conditions. The discount rate used to determine the present

value of future cash flows is based on the weighted-average cost of capital adjusted for the relevant risk associated with business-specific

characteristics and the uncertainty related to the business's ability to execute on the projected cash flows. The market approach estimates

fair value based on market multiples of revenue and earnings derived from comparable publicly traded companies with similar operating

and investment characteristics. The resulting fair value, based on the income and market approaches, is then compared to the carrying

value to determine if impairment is necessary.

Lifeway assesses whether indefinite-lived intangible

asset impairment exists using both qualitative and quantitative assessments annually in the fourth quarter or more frequently, if certain

conditions exist. The qualitative assessment involves determining whether events or circumstances exist that indicate it is more likely

than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, based on this qualitative assessment,

the Company determines it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying

amount or if it elects not to perform a qualitative assessment, a quantitative assessment is performed to determine whether an indefinite-lived

intangible asset impairment exists. Lifeway tests the indefinite-lived intangible assets for impairment by comparing the carrying value

to the fair value based on current revenue projections of the related operations, under the relief from royalty method. Any excess of

the carrying value over the amount of fair value is recognized as an impairment. Any such impairment would be recognized in full in the

reporting period in which it has been identified.

Definite lived intangible assets

Intangible assets acquired in a business combination

are recorded at their estimated fair values at the date of acquisition. Identifiable intangible assets with finite lives are amortized

over their estimate useful lives as follows:

Schedule Of Intangible Assets Useful Lives

Asset Useful Life

Recipes 4 years

Brand names 8-15 years

Formula 10 years

Customer lists 5-10 years

Customer relationships 15 years

All amortization expense related to intangible assets is recorded in

Amortization expense in the consolidated statements of operations.

Amortizable intangible assets are evaluated for

impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Lifeway conducts more

frequent impairment assessments if certain conditions exist, such as a change in the competitive landscape, any internal decisions to

pursue new or different strategies, a loss of a significant customer, or a significant change in the market place including changes in

the prices paid for its products or changes in the size of the market for its products. If an evaluation of the undiscounted cash flows

indicates impairment, the asset is written down to its estimated fair value, which is generally based on discounted future cash flows.

If the estimated remaining useful life of an intangible asset is changed, the remaining carrying amount of the intangible asset is amortized

prospectively over the revised remaining useful life.

Fair value measurements

Fair value is estimated by applying the following

hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy

upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 – Quoted prices in

active markets for identical assets or liabilities.

Level 2 – Observable inputs

other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities

in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term

of the assets or liabilities.

Level 3. Inputs that are generally

unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset

or liability.

Lifeway’s financial assets and liabilities

that are not carried at fair value on a recurring basis include cash and cash equivalents, accounts receivable, other receivables, accounts

payable, accrued expenses and revolving line of credit for which carrying value approximates fair value.

The Company records its investments in equity

securities without a readily determinable fair value at cost minus impairment, if any, plus or minus changes resulting from observable

price changes in orderly transactions for the identical or a similar investment of the same issuer. As of December 31, 2021, and 2020,

the Company has one investment without a readily determinable fair value which is recorded at $1,800 in other assets on the consolidated

balance sheet. The investment cost of $1,800 includes a cumulative unrealized gain of $1,731 resulting from an observable price

change in 2019. There were no upward or downward adjustments to the investment cost during 2021 or 2020.

Income taxes

The Provision for income taxes includes federal,

state, local and foreign income taxes currently payable, and those deferred because of temporary differences between the financial statement

and tax bases of assets and liabilities. Deferred tax assets or liabilities are computed based on the difference between the financial

statement and income tax bases of assets and liabilities using enacted tax rates expected to apply to taxable income in the year in which

the deferred tax assets or liabilities are expected to be realized or settled. The principal sources of temporary differences are different

depreciation and amortization methods for financial statement and tax purposes, incentive compensation, unrealized gain, capitalization

of indirect inventory costs for tax purposes, reserves for excess and obsolete inventory and the allowance for doubtful accounts. Valuation

allowances are recorded to reduce deferred tax assets when it is more likely not that a tax benefit will not be realized. Deferred income

tax expense or benefit is based on the changes in the asset or liability from period to period.

Lifeway analyzes filing positions in all the federal

and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The Company

recognizes the income tax benefit from an uncertain tax position when it is more likely than not that, based on technical merits, the

position will be sustained upon examination, including resolutions of any related appeals or litigation processes. It applies a more likely

than not threshold to the recognition and derecognition of uncertain tax positions. Accordingly, Lifeway recognizes the amount of tax

benefit that has a greater than 50% likelihood of being ultimately realized upon settlement. Future changes in judgment related to the

expected ultimate resolution of uncertain tax positions will affect earnings in the period of such change. For those income tax positions

where it is not more likely than not that a tax benefit will be sustained, no tax benefit has been recognized in the financial statements.

The total amount of unrecognized tax benefits can change due to audit settlements, tax examination activities, statute expirations and

the recognition and measurement criteria under accounting for uncertainty in income taxes. Lifeway recognizes penalties and interest related

to unrecognized tax benefits in the provision (benefit) for income taxes in the consolidated statements of operations.

Share-based compensation

Source: SEC EDGAR (public domain) · 10-K for the period ended 2021-12-31, filed 2022-07-21 · accession 0001683168-22-005054

Filing HTML rendered to line-structured narrative text by the shipped reducer (datafeeds.edgar_fulltext.visible_text, keep_table_headers=True): scripts and inline-XBRL headers are dropped, and table content is reduced to its short label cells — numeric table data is not rendered and is therefore not counted. The same rendering is used for every year, so a year-over-year comparison is like for like.

The text is our rendering of the filing, not a facsimile: original pagination, typography and tables are not reproduced, and the numbers live in the financial statements (FA).

The outline locates item HEADINGS in this document. Only Items 1A and 7 have certified boundaries elsewhere in the terminal (the redline and the narrative-overlap number); every span here runs from one heading found to the next heading found.

How the outline was chosen. It is the longest chain of item headings that runs forward through both the document and the standard item order: 22 headings are on that chain and 16 further heading-shaped lines are not — the table-of-contents echo of every item, cross-references and exhibit-list mentions. Each entry's length is measured from its heading to the next heading on the chain.